The PM Society’s 38th annual awards were held last week, on Friday 15th March, at the JW Marriott Grosvenor House London, at which over 900 industry professionals came tog
In an era where digital transformation is not just a choice, but a necessity, pharmaceutical companies are quickly adapting to meet the needs of their healthcare providers and patients.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh